We are live on ! Find out more
CBMG

Cellular Biomedicine Group, Inc.
CBMG

Delisted

CBMG was delisted on the 19th of February, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of CBMG yet.

CBMG Hedge Fund Activity: Q1 2021 in Review

0 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cellular Biomedicine Group, Inc. (CBMG) for Q1 2021, worth a combined $0 — down 100% from $80M a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of CBMG and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $16.1M sold.

  • 0 institutional investors held Cellular Biomedicine Group, Inc. (CBMG) as of Q1 2021, down from 67 in Q4 2020.
  • Funds reported $0 of Cellular Biomedicine Group, Inc. stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Cellular Biomedicine Group, Inc. positions in Q1 2021 and 66 closed out, a net change of -66 holders.
  • The largest Cellular Biomedicine Group, Inc. seller in Q1 2021 was BlackRock, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2021.